Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download ChromeDownload Microsoft Edge

We never sell data.

We never share data.

Data never leaves Sensyne.

We only use data for the purposes of medical research to improve patient outcomes and accelerate the development of new medicines.

Sensyne Health | The future of healthcare

Our mission

To improve health and create wealth for all through the ethical application of clinical artificial intelligence and the creation of a trusted data community between patients, clinicians, healthcare providers and life science companies that is transparent, fair and effective.

Sensyne Health is a clinical artificial intelligence company operating a unique business model. We are a for-profit plc making a positive social impact, sharing the financial returns we make with the health systems via equity and a share of revenues.

The company applies Clinical AI in two markets:

Our work

MagnifEye - For Lateral Flow Tests

Fast and accurate AI-based interpretation of Lateral Flow Tests

MagnifEye is an AI-powered software product that transforms any smartphone into an easy-to-use Lateral Flow Test (LFT) reader.

More about MagnifEye

A unique approach

We have created a unique commercial approach to benefit patients, healthcare providers and the life science industry – a for-profit plc making a positive social impact. Providing both a financial return to health systems via equity and/or a share in revenues, and a patient outcome ‘return’ advancing care delivery and disease research and development.

Our Strategic Research Agreements (SRAs) with healthcare providers allow us access to globally unique, longitudinal de-identified and anonymised patient datasets.

Strategic Research Agreements


Latest news